Skip Navigation
Menu
Letters |21 August 2012

Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease

William Kussmaul, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • From Hahnemann University Hospital, Philadelphia, PA 19102.

    Potential Conflicts of Interest: None disclosed.

×
FULL TEXT
TO THE EDITOR:
Palmer and colleagues (1) have usefully collected information on the use of antiplatelet agents in patients who have both coronary artery disease and chronic kidney disease (CKD). They conclude that the benefits of both primary and secondary prevention are uncertain and that patients who have CKD may have a greater risk for bleeding. The review also implies that these agents should not be used in patients with CKD until better data are available.
Unfortunately, Palmer and colleagues may have done a disservice to the many patients with CKD who have coronary stents and to their physicians. Almost all patients receiving stents are required to take aspirin and a thienopyridine (most often clopidogrel) for 30 days or up to 12 months, depending on the type of stent, to prevent acute coronary stent thrombosis, a very dangerous event.
FULL TEXT
PDF
Not Available
Citations
Citation

Kussmaul W. Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease. Ann Intern Med. ;157:302. doi: 10.7326/0003-4819-157-4-201208210-00023

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2012;157(4):302.

DOI: 10.7326/0003-4819-157-4-201208210-00023

1 Citations
CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×